Company: RGNT
Filing Date: 2025-03-11
Form Type: F-1
Source: 0001213900-25-022350
Chunk: 109

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-03-11
Form: F-1
Chunk 109
---
4.1 million and net cash of $1.2 million was used in our operating activities. For the six months ended June 30, 2024, we incurred a net income of $7.2 million while net cash of $ 0.006 million was provided by our operating activities. As of June 30, 2024 and December 31, 2023, we had a negative working capital of $0.9 million and $2.8 million, respectively, and an accumulated deficit of approximately $39.7 million and $46.9 million, respectively. As of June 30, 2024, our cash and cash equivalents totaled approximately $0.2 million. We believe that after the completion of this offering our cash and cash equivalents, including the proceeds from this offering, will enable us to fund our operations through March 31, 2027.

Through June 30, 2024, we
have financed our operations primarily through private placements and convertible loans. Total invested capital as of June 30, 2024 was
$35.7 million, which included Ordinary Shares, Preferred Shares and warrants to purchase Preferred Shares.

The following table summarizes
our statement of cash flows for the years ended December 31, 2023 and 2022 and the six months periods ended June 30, 2024 and 2023:

| (U.S. dollars in thousands except share and per share data) |     | For the Six Months Ended 
 June                     
 30,                      
 2024                     |      |   |     | 2023 |      |   |     | For the Years Ended 
 December            
 31,                 
 2023                |        |   |     | 2022 |          |   |
|:------------------------------------------------------------|:----|:-------------------------|-----:|:--|:----|:-----|:-----|:--|:----|:--------------------|-------:|:--|:----|:-----|:---------|:--|
| Net cash used in operating activities                       |     | $                        |    6 |   |     |      | (755 | ) |     | $                   | (1,220 | ) |     |      | ‌(1,504) |   |
| Net cash used in investing activities                       |     |                          |    - |   |     |      | -    |   |     |                     |      - |   |     |      | -